Kevin Fischbeck
Stock Analyst at B of A Securities
(3.98)
# 556
Out of 5,154 analysts
188
Total ratings
63.64%
Success rate
6.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintains: Buy | $32 → $35 | $29.84 | +17.29% | 2 | Dec 9, 2025 | |
| ACHC Acadia Healthcare Company | Downgrades: Underperform | $22 → $13 | $25.62 | -49.26% | 9 | Dec 3, 2025 | |
| ARDT Ardent Health | Maintains: Underperform | $12 → $10 | $8.90 | +12.36% | 4 | Nov 13, 2025 | |
| HUM Humana | Maintains: Neutral | $280 → $300 | $179.15 | +67.46% | 17 | Oct 10, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $330 → $370 | $289.64 | +27.74% | 4 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $286.48 | +36.14% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $21.27 | -15.37% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $150.76 | -7.14% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $236.95 | -5.04% | 8 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $106.95 | +49.60% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $30 | $43.65 | -31.27% | 13 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $215 → $185 | $192.65 | -3.97% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $532.81 | -23.05% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 | $0.60 | +401.42% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $144.47 | +203.87% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.49 | -31.51% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $18.44 | -60.68% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $271.63 | +28.85% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $13.36 | +236.83% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.35 | +64.18% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $16.25 | +115.38% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.00 | +400.00% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $9.82 | -23.63% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $19.75 | - | 3 | Sep 6, 2019 |
Option Care Health
Dec 9, 2025
Maintains: Buy
Price Target: $32 → $35
Current: $29.84
Upside: +17.29%
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Underperform
Price Target: $22 → $13
Current: $25.62
Upside: -49.26%
Ardent Health
Nov 13, 2025
Maintains: Underperform
Price Target: $12 → $10
Current: $8.90
Upside: +12.36%
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $179.15
Upside: +67.46%
Elevance Health
Oct 10, 2025
Maintains: Neutral
Price Target: $330 → $370
Current: $289.64
Upside: +27.74%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $286.48
Upside: +36.14%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $21.27
Upside: -15.37%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $150.76
Upside: -7.14%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $236.95
Upside: -5.04%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $106.95
Upside: +49.60%
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $43.65
Upside: -31.27%
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $192.65
Upside: -3.97%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $532.81
Upside: -23.05%
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $0.60
Upside: +401.42%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $144.47
Upside: +203.87%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.49
Upside: -31.51%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $18.44
Upside: -60.68%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $271.63
Upside: +28.85%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $13.36
Upside: +236.83%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.35
Upside: +64.18%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $16.25
Upside: +115.38%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.00
Upside: +400.00%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $9.82
Upside: -23.63%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $19.75
Upside: -